Recital 10, Commission Regulation (EC) No 1112/2002 of 20 June 2002 laying down the detailed rules f…

In force

It is appropriate for manufacturers to bear the costs of the evaluation needed to demonstrate that their products are safe to market and therefore a fee has to be paid to the authority designated by the Commission to examine the notifications for the active substances.